rCSP/AP10-602 [GLA-LSQ] Vaccine Trial

NCT03589794 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Infection

Interventions

OTHER: AP10-602
OTHER: Malaria challenge
BIOLOGICAL: rCSP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)